Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
作者
Stephen J Thomas,Edson D. Moreira,Nicholas Kitchin,Judith Absalon,Alejandra Gurtman,Stephen Lockhart,John L. Perez,Gonzalo Perez Marc,Fernando P Polack,Cristiano Zerbini,Ruth Bailey,Kena A. Swanson,Xia Xu,Satrajit Roychoudhury,Kenneth Koury,Salim Bouguermouh,Warren V. Kalina,David Cooper,Robert W. Frenck,Laura L Hammitt
Through 6 months of follow-up and despite a gradual decline in vaccine efficacy, BNT162b2 had a favorable safety profile and was highly efficacious in preventing Covid-19. (Funded by BioNTech and Pfizer; ClinicalTrials.gov number, NCT04368728.).
PDF的下载单位、IP信息已删除
BowieHuang
ceeray23
Criminology34
VDC
大龙哥886
无情的踏歌
hovumath
无极微光
无解
morena
寻道图强
mmyhn
GY97
嘿嘿
YifanWang
遇上就这样吧
nn
着急的青枫
轻松的玉米
斯文败类
卷卷
优美的小笨蛋
zik
子车茗
皖公网安备34019202002308
